33632987|t|Optimal Hypoxic Preconditioning of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells (hES-MSCs) and Their Characteristics.
33632987|a|BACKGROUND AND OBJECTIVES: Hypoxia is frequently used to enhance stem cell function. However, the optimal level of hypoxia for growth and function of human embryonic stem cell-derived mesenchymal stem cells (hES-MSCs) is yet to be determined. The purpose of this study was to find the optimal level of hypoxia for hES-MSCs and characteristics of hES-MSCs cultured under these optimal hypoxic conditions. METHODS AND RESULTS: Cell viability and changes in the morphology of hES-MSCs were determined through cell proliferation and CCK-8 assay. The hES-MSCs were preconditioned under various hypoxic conditions (0.5~5% O2 and 24~72 h). The expression of cytokines in each culture condition was compared using cytokine array analysis. The morphology of hES-MSCs did not change under various hypoxic culture conditions. hES-MSCs viability after 48 h incubation in 2% O2 condition was higher than that in normoxic condition. HIF1alpha expression was increased up to six folds after 48 h of hypoxic preconditioning. HIF1alpha expression in hES-MSCs peaked after 48 h of incubation in 1% O2 condition. The expressions of PDGF-BB, IGFBP-6, VEGF-A, and angiogenin were increased after hES-MSCs were incubated for 48 h in 2% O2 condition. CONCLUSIONS: The hES-MSCs viability and expressions of PDGF-BB, IGFBP-6, VEGF-A, and angiogenin increased after 48 h incubation in 2% O2 condition.
33632987	8	15	Hypoxic	Disease	MESH:D002534
33632987	35	40	Human	Species	9606
33632987	93	101	hES-MSCs	CellLine	CVCL:JE75
33632987	157	164	Hypoxia	Disease	MESH:D000860
33632987	245	252	hypoxia	Disease	MESH:D000860
33632987	280	285	human	Species	9606
33632987	338	346	hES-MSCs	CellLine	CVCL:JE75
33632987	432	439	hypoxia	Disease	MESH:D000860
33632987	444	452	hES-MSCs	CellLine	CVCL:JE75
33632987	476	484	hES-MSCs	CellLine	CVCL:JE75
33632987	514	521	hypoxic	Disease	MESH:D002534
33632987	603	611	hES-MSCs	CellLine	CVCL:JE75
33632987	659	664	CCK-8	Chemical	MESH:D012844
33632987	676	684	hES-MSCs	CellLine	CVCL:JE75
33632987	719	726	hypoxic	Disease	MESH:D002534
33632987	746	748	O2	Chemical	-
33632987	879	887	hES-MSCs	CellLine	CVCL:JE75
33632987	917	924	hypoxic	Disease	MESH:D002534
33632987	945	953	hES-MSCs	CellLine	CVCL:JE75
33632987	992	994	O2	Chemical	-
33632987	1049	1058	HIF1alpha	Gene	3091
33632987	1114	1121	hypoxic	Disease	MESH:D002534
33632987	1139	1148	HIF1alpha	Gene	3091
33632987	1163	1171	hES-MSCs	CellLine	CVCL:JE75
33632987	1210	1212	O2	Chemical	-
33632987	1252	1259	IGFBP-6	Gene	3489
33632987	1261	1267	VEGF-A	Gene	7422
33632987	1273	1283	angiogenin	Gene	283
33632987	1305	1313	hES-MSCs	CellLine	CVCL:JE75
33632987	1344	1346	O2	Chemical	-
33632987	1375	1383	hES-MSCs	CellLine	CVCL:JE75
33632987	1422	1429	IGFBP-6	Gene	3489
33632987	1431	1437	VEGF-A	Gene	7422
33632987	1443	1453	angiogenin	Gene	283
33632987	1492	1494	O2	Chemical	-
33632987	Positive_Correlation	MESH:D000860	3091
33632987	Positive_Correlation	MESH:D002534	3091

